← National Community Pharmacists Association
EBSARulemakingEBSA-2026-0001

Improving Transparency Into Pharmacy Benefit Manager Fee Disclosure

RIN
—
Last modified
Jan 30, 2026
Comment window
closed 119d ago
National Community Pharmacists Association filings
1

Activity

National Community Pharmacists Association filed 1 comment on this docket between Apr 15, 2026 and Apr 15, 2026. 4 other organizations filed here. The comment window closed 119d ago.

What National Community Pharmacists Association filed (1)

Apr 15, 2026· 1210-AB37 comment 0119 National Community Pharmacists Association NCPA 04152026· EBSA-2026-0001-0478

The National Community Pharmacists Association (NCPA) appreciates the opportunity to provide comments to the Employee Benefits Security Administration of the Department of Labor on the Improving Transparency Into Pharmacy Benefit Manager Fee Disclosure proposed rule. Our full comments are attached. NCPA argues that Department should finalize this rule, as well as NCPA's additional suggestions, and move forward with implementation on July 1, 2026 as indicated in the Proposed Rule. NCPA thanks the Department for the opportunity to provide feedback, and we stand ready to work with the agency to offer possible solutions and ideas. Please let us know how we can assist further, and should you have any questions or concerns, please feel free to contact me at steve.postal@ncpa.org or (703) 600-1178.

Download attachment ↓View on regulations.gov →

Abstract

The Department is proposing a regulation that would require providers of pharmacy benefit management services and affiliated providers of brokerage and consulting services to disclose information about their compensation to fiduciaries of self-insured group health plans subject to the Employee Retirement Income Security Act (ERISA). These disclosures are needed so that fiduciaries can assess the reasonableness of the contracts or arrangements with these service providers, including the reasonableness of the service providers' compensation. These disclosure requirements would apply for purposes of ERISA's statutory prohibited transaction exemption for services arrangements. This proposal implements section 12 of President Trump's Executive Order 14273, Lowering Drug Prices by Once Again Putting Americans First, which instructs the Department to propose regulations to improve employer health plan transparency into the direct and indirect compensation received by pharmacy benefit managers. If finalized, this regulation would affect sponsors and other fiduciaries of self-insured group health plans and certain service providers to such plans.

View on regulations.gov →

Co-filers (4)

See everyone who commented →